Javelin Pharmaceuticals, Inc

(AMEX:JAV)

Key Stats & Ratios

Valuation
Market Cap 87.90M
P/E
P/E (Trailing) -1.85
P/E (Forward)
Price/Sales 120.00
Price/Book 2.14
EPS -0.74
EPS Growth (ttm)
Fiscal Year
Fiscal Year Ends Dec 31
Last Quarter Jun 2008
Profitability
Operating Income -40710593.00
Net Income -39376751.00
Profit Margin (ttm)
Operating Margin (ttm) -66.59%
Management Effectiveness
Return on Assets (ttm) -88.60%
Return on Equity (ttm)
EBIT Margin (ttm)
Memberships
Russel 2000
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 38.08M
Revenue 611.35K
Revenue/Share 0.01
Revenue Growth (ytd)
Annual Revenue Growth Rate (3Y)
Annual Income Growth Rate (3Y)
Earnings Growth (ytd)
Gross Operating Profit (ttm) 332.29K
EBITDA -40302802.00
Diluted EPS (ttm) -0.74
Balance Sheet
Total Cash 34.55M
Total Cash/Share 0.57
Total Assets 44.45M
Total Liabilities 10.71M
Total Debt/Equity
Long Term Debt Common Equity Ratio
Current Ratio 3.00
Leverage Ratio 1.00
Book Value/Share 0.56
Cash Flow
Cash Flow -38968960.00
Free Cash Flow -27087386.00
Cash Flow/Share -0.64
Free Cash Flow/Share -0.45

Trading Information

Stock Price History
Beta
52Wk Change -60.60%
52Wk Change Vs. Mkt -41.00%
52Wk High 4.39
52Wk Low 0.40
10 Day Moving Average 1.26
200 Day Moving Average 2.20
Share Statistics
Average Volume 151.30K
Shares Outstanding 60.62M
Shares Float 55.74M
% Held by Insiders 8.10%
% Held by Institutions 48.30%
Shares Short (As of Dec 10, 2008) 2.89M
Short Ratio 4.00
Short % of Float 5.20%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount